Chain Drug Review - Glaxo products
Advair HFA inhalation is now on the market. Manufactured by GlaxoSmithKline PLC, the medicine is used to treat asthma. The FDA has also approved the company’s Coreg for treating hypertension, post-myocardial infarction left ventricular dysfunction, and mild-to-severe heart attack.
Related Results
Trial data added to coreg labelNew indications for once-daily CoregFlamel Technologies Welcomes FDA Approval of COREG CR™Flamel Technologies Welcomes Nationwide Availability of COREG CR™New & approved: Coreg biotronik home monitoring system
COPYRIGHT 2006 Racher Press, Inc.
COPYRIGHT 2008 Gale, Cengage Learning
